* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Factors Affecting Drug
Survey
Document related concepts
Transcript
Quantitative Pharmacokinetics Drug-Protein Binding Dr. Chalet Tan 1 Learning Objectives proteins that bind drugs and types of protein binding factors affecting drug-protein binding effect of protein binding on drug distribution Required reading: Tozer & Rowland, Introduction to Pharmacokinetics and Pharmacodynamics, Chapter 5, p83-89. 2 Relevance of Drug-Protein Binding to Drug Therapy protein-bound drugs are pharmacologically inactive protein-bound drugs does not cross cell membranes, affecting: distribution metabolism excretion 3 Types of Drug-Protein Binding reversible • weak chemical bonds such as hydrogen bonds or van der Waals forces • occurs to most drugs irreversible • covalent chemical bonds • accounts for certain toxicities of drugs and carcinogens e. g. high doses of acetaminophen 4 Major Drug-Binding Proteins in Plasma TABLE 5-3 albumin: binds mostly to acidic drugs a1-acid glycoprotein: binds mostly to basic drugs lipoproteins: binds mostly to neutral drugs 5 The fraction of unbound drug in plasma varies widely among drugs 0 ≤ fu ≤ 1 Figure 5-13 6 Methods for Studying Drug-Protein Binding equilibrium dialysis ultracentrifuge gel chromatography electrophoresis For the ease of chemical analysis, total plasma concentrations of drugs (instead of unbound drug concentrations) are most commonly measured. 7 Drug-Protein Binding Affects Drug Distribution Figure 5-14 8 Drug-Protein Binding Affects Drug Distribution at equilibrium, Cu = CuT 9 Drug-Protein Binding Affects Drug Distribution V: volume of distribution Vp: volume of the plasma VT: volume of the tissue fu : free fraction of the drug in the plasma fuT : free fraction of the drug in the tissue VT of a drug is dependent on its physicochemical properties. 10 V and Volumes of Body Water For a 70-kg healthy individual, extracellular plasma 3L interstitial fluids 13 L intracellular 26 L Total 42 L V rarely correlates to a real volume. V of drugs with MW > 70 KD is close to 3 L. V of small MW drugs that are neither bound in plasma nor 11 in tissue is between 16 – 42 L. Factors Affecting Drug-Protein Binding drug • physicochemical properties • concentration protein • physicochemical properties • concentration displacement by co-administered drugs e. g. increased free warfarin level when co-administered with salicylic acid (displacer) 12 Displacement may occur if: the drug (e. g. warfarin) is highly protein-bound; and the displacer (e. g. salicylic acid) occupies most of the binding site. Factors Affecting Drug-Protein Binding pathophysiological conditions of the patients 14 V of propranolol is proportional to its fu in plasma. control patients with chronic hepatic disease Figure 5-15 15 Plasma Protein Binding Determines the Distribution of Many Drugs 16 V of Some Drugs Does Not Depend on Plasma Protein Binding 17 Furosemide and amiodarone have fu between 0.02-0.04, an acidic and a basic drug respectively. Yet, the former has a V of 10 L and the latter 7000 L. What contributes to this difference? 18